Vascular dementia is one of the most common types of dementia, and it happens when the brain does not get enough blood flow.
The brain needs a constant supply of oxygen and nutrients from the blood to work properly. When this supply is reduced, brain cells can become damaged or die over time. This can lead to problems with memory, thinking, and daily activities.
Dementia is already a major global health concern, and the number of people living with it is rising quickly. Today, around 55 million people worldwide are affected, and this number could grow to 139 million by 2050. Because of this, scientists are urgently searching for new ways to prevent or treat these conditions.
A recent study published in the journal Alzheimer’s & Dementia has explored an unexpected idea. Researchers looked at tadalafil, a drug commonly used to treat erectile dysfunction, to see if it could also help improve brain health in people at risk of vascular dementia.
Tadalafil belongs to a group of drugs that help relax blood vessels and improve blood flow. Other drugs in this group include sildenafil and vardenafil.
These medications are widely used and well understood, which makes them interesting candidates for new uses. Scientists have suggested that if these drugs can improve blood flow in other parts of the body, they might also help increase blood flow to the brain.
Better blood flow in the brain could help protect brain cells and possibly slow down damage linked to dementia. This idea has led researchers to test whether tadalafil could be useful for people with reduced blood supply in the brain.
Tadalafil was chosen for this study because it stays in the body longer than similar drugs. This longer effect means it might have more time to reach the brain and produce benefits. Researchers believed this could make it a stronger option for studying brain-related conditions.
The study was a phase II clinical trial supported by the Alzheimer’s Drug Discovery Foundation in the United States and the Alzheimer’s Society in the United Kingdom. It focused on older adults who had narrowing in the arteries of the brain. This condition reduces blood flow and increases the risk of strokes and vascular dementia.
To measure blood flow in the brain, researchers used a special MRI method called arterial spin labeling. This technique allows scientists to track blood flow without using injections or radiation, making it safe and comfortable for participants.
The results of the study were mixed. Overall, there was no clear difference in brain blood flow between the group that took a single dose of tadalafil and the group that received a placebo. This means that one dose of the drug did not show a strong effect in improving blood flow.
However, the researchers noticed something interesting when they looked more closely at the data. In participants over the age of 70, there was a small sign of improved blood flow in a part of the brain known as white matter. This area is important because it is often damaged in people with vascular dementia.
Although this improvement was not strong enough to be considered a clear result, it suggests that the drug might have some effect in certain groups of people. This finding gives researchers a reason to continue studying the drug in more detail.
Another important result from the study was safety. There were no serious side effects reported among the participants. This is encouraging because it shows that tadalafil is likely safe for older adults, at least in the short term.
Experts involved in the research believe that the lack of strong results may be due to the way the study was designed. Taking only a single dose of the drug may not be enough to create noticeable changes in the brain. Longer-term treatment might be needed to see real benefits.
Researchers also point out that using existing drugs in new ways is a smart strategy. Since tadalafil is already widely used and its safety is well known, it could move more quickly into further testing compared to brand-new drugs.
While this study does not prove that tadalafil can treat or prevent vascular dementia, it opens the door to new possibilities. Future research may test different doses, longer treatment periods, or combinations with other therapies.
For now, the findings offer cautious hope. They remind us that sometimes new treatments can come from unexpected places. A drug originally designed for one purpose may one day help with a completely different condition.
As scientists continue to explore these ideas, studies like this bring us one step closer to better ways of protecting brain health and improving the lives of people at risk of dementia.
If you care about cancer, please read studies that a low-carb diet could increase overall cancer risk, and vitamin D supplements could strongly reduce cancer death.
For more information about health, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing higher intake of dairy foods linked to higher prostate cancer risk.
Copyright © 2026 Knowridge Science Report. All rights reserved.
